# A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants

> **NCT07146750** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 212 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **COMBINATION_PRODUCT:** SAR445229

## Key facts

- **NCT ID:** NCT07146750
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-25
- **Primary completion:** 2026-04-08
- **Final completion:** 2026-04-08
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07146750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07146750, "A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07146750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*